Cargando…

Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies

Salmonid Rickettsial Septicemia (SRS) is the disease of greatest economic importance in the Chilean salmon farming industry, causing high mortality in fish during the final stage of their productive cycle at sea. Since current, commercially available vaccines have not demonstrated the expected effic...

Descripción completa

Detalles Bibliográficos
Autores principales: San Martín, Betty, Fresno, Marcela, Cornejo, Javiera, Godoy, Marcos, Ibarra, Rolando, Vidal, Roberto, Araneda, Marcelo, Anadón, Arturo, Lapierre, Lisette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513110/
https://www.ncbi.nlm.nih.gov/pubmed/31083666
http://dx.doi.org/10.1371/journal.pone.0215174
_version_ 1783417729046282240
author San Martín, Betty
Fresno, Marcela
Cornejo, Javiera
Godoy, Marcos
Ibarra, Rolando
Vidal, Roberto
Araneda, Marcelo
Anadón, Arturo
Lapierre, Lisette
author_facet San Martín, Betty
Fresno, Marcela
Cornejo, Javiera
Godoy, Marcos
Ibarra, Rolando
Vidal, Roberto
Araneda, Marcelo
Anadón, Arturo
Lapierre, Lisette
author_sort San Martín, Betty
collection PubMed
description Salmonid Rickettsial Septicemia (SRS) is the disease of greatest economic importance in the Chilean salmon farming industry, causing high mortality in fish during the final stage of their productive cycle at sea. Since current, commercially available vaccines have not demonstrated the expected efficacy levels, antimicrobials, most commonly florfenicol, are still the main resource for the treatment and control of this pathogen. The aim of this study was to determine the most appropriate single dose of florfenicol, administered through medicated feed, for the treatment of Piscirickettsia salmonis (P. salmonis), using pharmacokinetic/pharmacodynamic (PK/PD) models. Previously, Minimum Inhibitory Concentrations (MICs) of florfenicol were determined for 87 P. salmonis isolates in order to define the epidemiological cut-off point (CO(WT)). The most commonly observed MIC was 0.125 μg mL(-1) (83.7%). The CO(WT) value was 0.25 μg mL(-1) with a standard deviation of 0.47 log(2) μg mL(-1) and 0.36 log(2) μg mL(-1), for Normalized resistance interpretation (NRI) method and ECOFFinder method, respectively. A MIC of 1 μg mL(-1) was considered the pharmacodynamic value (PD) to define PK/PD indices. Three doses of florfenicol were evaluated in fish farmed under controlled conditions. For each dose, 150 fish were used and blood plasma samples were collected at different time points (0–48 hours). PK parameters were obtained from curves representing plasma concentrations as a function of time. The results of Monte Carlo simulation indicate that at a dose of 20 mg/Kg l.w. of florfenicol, administered orally as medicated feed, there is 100% probability (PTA) of achieving the desired efficacy (AUC(0-24h)/MIC>125). According to these results, we suggest that at the indicated dose, the PK/PD cut-off point for florfenicol versus P. salmonis could be 2 μg mL(-1) (PTA = 99%). In order to assess the indicated dose in Atlantic salmon, fish were inoculated with P. salmonis LF-89 strain and then treated with the optimized dose of florfenicol, 20 mg/Kg bw for 15 days.
format Online
Article
Text
id pubmed-6513110
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65131102019-05-31 Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies San Martín, Betty Fresno, Marcela Cornejo, Javiera Godoy, Marcos Ibarra, Rolando Vidal, Roberto Araneda, Marcelo Anadón, Arturo Lapierre, Lisette PLoS One Research Article Salmonid Rickettsial Septicemia (SRS) is the disease of greatest economic importance in the Chilean salmon farming industry, causing high mortality in fish during the final stage of their productive cycle at sea. Since current, commercially available vaccines have not demonstrated the expected efficacy levels, antimicrobials, most commonly florfenicol, are still the main resource for the treatment and control of this pathogen. The aim of this study was to determine the most appropriate single dose of florfenicol, administered through medicated feed, for the treatment of Piscirickettsia salmonis (P. salmonis), using pharmacokinetic/pharmacodynamic (PK/PD) models. Previously, Minimum Inhibitory Concentrations (MICs) of florfenicol were determined for 87 P. salmonis isolates in order to define the epidemiological cut-off point (CO(WT)). The most commonly observed MIC was 0.125 μg mL(-1) (83.7%). The CO(WT) value was 0.25 μg mL(-1) with a standard deviation of 0.47 log(2) μg mL(-1) and 0.36 log(2) μg mL(-1), for Normalized resistance interpretation (NRI) method and ECOFFinder method, respectively. A MIC of 1 μg mL(-1) was considered the pharmacodynamic value (PD) to define PK/PD indices. Three doses of florfenicol were evaluated in fish farmed under controlled conditions. For each dose, 150 fish were used and blood plasma samples were collected at different time points (0–48 hours). PK parameters were obtained from curves representing plasma concentrations as a function of time. The results of Monte Carlo simulation indicate that at a dose of 20 mg/Kg l.w. of florfenicol, administered orally as medicated feed, there is 100% probability (PTA) of achieving the desired efficacy (AUC(0-24h)/MIC>125). According to these results, we suggest that at the indicated dose, the PK/PD cut-off point for florfenicol versus P. salmonis could be 2 μg mL(-1) (PTA = 99%). In order to assess the indicated dose in Atlantic salmon, fish were inoculated with P. salmonis LF-89 strain and then treated with the optimized dose of florfenicol, 20 mg/Kg bw for 15 days. Public Library of Science 2019-05-13 /pmc/articles/PMC6513110/ /pubmed/31083666 http://dx.doi.org/10.1371/journal.pone.0215174 Text en © 2019 San Martín et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
San Martín, Betty
Fresno, Marcela
Cornejo, Javiera
Godoy, Marcos
Ibarra, Rolando
Vidal, Roberto
Araneda, Marcelo
Anadón, Arturo
Lapierre, Lisette
Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
title Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
title_full Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
title_fullStr Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
title_full_unstemmed Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
title_short Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies
title_sort optimization of florfenicol dose against piscirickettsia salmonis in salmo salar through pk/pd studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513110/
https://www.ncbi.nlm.nih.gov/pubmed/31083666
http://dx.doi.org/10.1371/journal.pone.0215174
work_keys_str_mv AT sanmartinbetty optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT fresnomarcela optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT cornejojaviera optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT godoymarcos optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT ibarrarolando optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT vidalroberto optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT aranedamarcelo optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT anadonarturo optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies
AT lapierrelisette optimizationofflorfenicoldoseagainstpiscirickettsiasalmonisinsalmosalarthroughpkpdstudies